Skip to main content
. 2005 Jul;64(7):1003–1008. doi: 10.1136/ard.2004.029124

Figure 3.

Figure 3

 Effect of infliximab treatment on plasma levels of (A) CRP and (B, C) CRP-complement complexes: (B) CRP-C3d; (C) CRP-C4d, which reflects CRP mediated complement activation. Note that both CRP and CRP-complement complexes significantly decreased upon treatment (p values for all panels are <0.001).